We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+2.13%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.22B
AUM Growth
+$77.6M
Cap. Flow
+$59.9M
Cap. Flow %
4.93%
Top 10 Hldgs %
46.33%
Holding
332
New
35
Increased
189
Reduced
69
Closed
18

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.41%
2 Technology 7.75%
3 Healthcare 2.78%
4 Financials 1.79%
5 Communication Services 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSX icon
251
Boston Scientific
BSX
$67.9B
$269K 0.02%
3,495
+484
+16% +$35.4K
GSK icon
252
GSK
GSK
$102B
$266K 0.02%
6,898
+985
+17% +$41.4K
DIA icon
253
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46B
$262K 0.02%
670
-536
-44% -$208K
CNI icon
254
Canadian National Railway
CNI
$76.2B
$260K 0.02%
2,200
-286
-12% -$35.8K
IYW icon
255
iShares US Technology ETF
IYW
$25.3B
$258K 0.02%
1,714
ACES icon
256
ALPS Clean Energy ETF
ACES
$112M
$257K 0.02%
+9,141
New +$266K
KLAC icon
257
KLA
KLAC
$229B
$256K 0.02%
+3,100
New +$229K
RACE icon
258
Ferrari
RACE
$73.9B
$250K 0.02%
611
+143
+31% +$59.4K
FITB
259
Fifth Third Bancorp
FITB
$49.5B
$248K 0.02%
6,800
RIO icon
260
Rio Tinto
RIO
$168B
$247K 0.02%
3,753
+584
+18% +$39.7K
MT icon
261
ArcelorMittal
MT
$56.1B
$246K 0.02%
10,734
-4,616
-30% -$118K
PSTX
262
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$246K 0.02%
84,080
+5,500
+7% +$15K
HSBC icon
263
HSBC
HSBC
$355B
$245K 0.02%
+5,633
New +$242K
MDLZ icon
264
Mondelez International
MDLZ
$79.6B
$245K 0.02%
3,741
+213
+6% +$14.6K
ADP icon
265
Automatic Data Processing
ADP
$114B
$243K 0.02%
+1,019
New +$250K
PXH icon
266
Invesco FTSE RAFI Emerging Markets ETF
PXH
$2.01B
$243K 0.02%
11,986
AGR
267
DELISTED
Avangrid, Inc.
AGR
$242K 0.02%
+6,825
New +$246K
SNPS icon
268
Synopsys
SNPS
$84.8B
$242K 0.02%
+407
New +$230K
IG icon
269
Principal Investment Grade Corporate Active ETF
IG
$202M
$241K 0.02%
11,762
DUK icon
270
Duke Energy
DUK
$93.8B
$241K 0.02%
2,400
+167
+7% +$16.7K
PYPL icon
271
PayPal
PYPL
$45.9B
$240K 0.02%
4,143
-37
-0.9% -$2.35K
BLK icon
272
Blackrock
BLK
$180B
$239K 0.02%
304
+47
+18% +$36.7K
GM icon
273
General Motors
GM
$75.7B
$238K 0.02%
5,133
+625
+14% +$28.2K
G icon
274
Genpact
G
$6.39B
$238K 0.02%
+7,387
New +$238K
OTIS icon
275
Otis Worldwide
OTIS
$27.3B
$238K 0.02%
2,470
+80
+3% +$7.71K

Similar funds

Callan Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Callan Capital held 332 positions worth $1.22B, up 6.8% from $1.14B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Callan Capital deployed $59.9M of net new capital in Q2 2024, opening 35 new positions and adding to 189 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 65,165 shares worth $3.81M.

By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, down from 86% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $1.96M trimmed.

  • Callan Capital's largest Q2 2024 buy was iShares Core S&P Mid-Cap ETF: 65,165 shares worth $3.81M.
  • Callan Capital added most to NVIDIA in Q2 2024, an estimated $18.4M increase.
  • Callan Capital's biggest Q2 2024 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $1.96M.
  • Callan Capital fully exited Takeda Pharmaceutical in Q2 2024, selling an estimated $354K.
  • Callan Capital's ten largest holdings make up 46% of its $1.22B portfolio in Q2 2024.
  • Callan Capital opened 35 new positions and closed 18 in Q2 2024.
  • Callan Capital's portfolio value rose 6.8% quarter-over-quarter to $1.22B.

Based on Callan Capital's 13F filing for Q2 2024, filed 12 Aug 2024.